Factors regulating ozone over the United States and its export to the global atmosphere

The factors regulating summertime O3 over the United States and its export to the global atmosphere are examined with a 3-month simulation using a continental scale, three-dimensional photochemical model. It is found that reducing NOx emissions by 50% from 1985 levels would decrease rural O3 concentrations over the eastern United States by about 15% under almost all meteorological conditions, while reducing anthropogenic hydrocarbon emissions by 50% would have less than a 4% effect except in the largest urban plumes. The strongly NOx-limited conditions in the model reflect the dominance of rural areas as sources of O3 on the regional scale. The correlation between O3 concentrations and temperature observed at eastern U.S. sites is attributed in part to the association of high temperatures with regional stagnation, and in part to an actual dependence of O3 production on temperature driven primarily by conversion of NOx to peroxyacetylnitrate (PAN). The net number of O3 molecules produced per molecule of NOx consumed (net O3 production efficiency, accounting for both chemical production and chemical loss of O3) has a mean value of 6.3 in the U.S. boundary layer; it is 3 times higher in the western United States than in the east because of lower NOx concentrations in the west. Approximately 70% of the net chemical production of O3 in the U.S. boundary layer is exported (the rest is deposited). Only 6% of the NOx emitted in the United States is exported out of the U.S. boundary layer as NOx or PAN, but this export contributes disproportionately to total U.S. influence on global tropospheric O3because of the high O3 production efficiency per unit NOx in the remote troposphere. It is estimated that export of U.S. pollution supplies 8 Gmol O3 d−1 to the global troposphere in summer, including 4 Gmol d−1 from direct export of O3 out of the U.S. boundary layer and 4 Gmol d−1 from production of O3 downwind of the United States due to exported NOx. This U.S. pollution source can be compared to estimates of 18–28 Gmol d−1 for the cross-tropopause transport of O3 over the entire northern hemisphere in summer

Effects of Anacetrapib in Patients with Atherosclerotic Vascular Disease

BACKGROUND: Patients with atherosclerotic vascular disease remain at high risk for cardiovascular events despite effective statin-based treatment of low-density lipoprotein (LDL) cholesterol levels. The inhibition of cholesteryl ester transfer protein (CETP) by anacetrapib reduces LDL cholesterol levels and increases high-density lipoprotein (HDL) cholesterol levels. However, trials of other CETP inhibitors have shown neutral or adverse effects on cardiovascular outcomes. METHODS: We conducted a randomized, double-blind, placebo-controlled trial involving 30,449 adults with atherosclerotic vascular disease who were receiving intensive atorvastatin therapy and who had a mean LDL cholesterol level of 61 mg per deciliter (1.58 mmol per liter), a mean non-HDL cholesterol level of 92 mg per deciliter (2.38 mmol per liter), and a mean HDL cholesterol level of 40 mg per deciliter (1.03 mmol per liter). The patients were assigned to receive either 100 mg of anacetrapib once daily (15,225 patients) or matching placebo (15,224 patients). The primary outcome was the first major coronary event, a composite of coronary death, myocardial infarction, or coronary revascularization. RESULTS: During the median follow-up period of 4.1 years, the primary outcome occurred in significantly fewer patients in the anacetrapib group than in the placebo group (1640 of 15,225 patients [10.8%] vs. 1803 of 15,224 patients [11.8%]; rate ratio, 0.91; 95% confidence interval, 0.85 to 0.97; P=0.004). The relative difference in risk was similar across multiple prespecified subgroups. At the trial midpoint, the mean level of HDL cholesterol was higher by 43 mg per deciliter (1.12 mmol per liter) in the anacetrapib group than in the placebo group (a relative difference of 104%), and the mean level of non-HDL cholesterol was lower by 17 mg per deciliter (0.44 mmol per liter), a relative difference of -18%. There were no significant between-group differences in the risk of death, cancer, or other serious adverse events. CONCLUSIONS: Among patients with atherosclerotic vascular disease who were receiving intensive statin therapy, the use of anacetrapib resulted in a lower incidence of major coronary events than the use of placebo. (Funded by Merck and others; Current Controlled Trials number, ISRCTN48678192 ; ClinicalTrials.gov number, NCT01252953 ; and EudraCT number, 2010-023467-18 .)

Sequence determinants of protein phase behavior from a coarse-grained model

<div><p>Membraneless organelles important to intracellular compartmentalization have recently been shown to comprise assemblies of proteins which undergo liquid-liquid phase separation (LLPS). However, many proteins involved in this phase separation are at least partially disordered. The molecular mechanism and the sequence determinants of this process are challenging to determine experimentally owing to the disordered nature of the assemblies, motivating the use of theoretical and simulation methods. This work advances a computational framework for conducting simulations of LLPS with residue-level detail, and allows for the determination of phase diagrams and coexistence densities of proteins in the two phases. The model includes a short-range contact potential as well as a simplified treatment of electrostatic energy. Interaction parameters are optimized against experimentally determined radius of gyration data for multiple unfolded or intrinsically disordered proteins (IDPs). These models are applied to two systems which undergo LLPS: the low complexity domain of the RNA-binding protein FUS and the DEAD-box helicase protein LAF-1. We develop a novel simulation method to determine thermodynamic phase diagrams as a function of the total protein concentration and temperature. We show that the model is capable of capturing qualitative changes in the phase diagram due to phosphomimetic mutations of FUS and to the presence or absence of the large folded domain in LAF-1. We also explore the effects of chain-length, or multivalency, on the phase diagram, and obtain results consistent with Flory-Huggins theory for polymers. Most importantly, the methodology presented here is flexible so that it can be easily extended to other pair potentials, be used with other enhanced sampling methods, and may incorporate additional features for biological systems of interest.</p></div

Toward a New Era of Research in Aerosol/Cloud/Climate Interactions at LLNL

One of the largest uncertainties in simulations of climate change over the industrial period is the impact of anthropogenic aerosols on the Earth's radiation budget. Much of this uncertainty arises from the limited capability for either precisely linking precursor gases to the formation and size distribution of the aerosols or quantitatively describing the existing levels of global aerosol loading. This project builds on our aerosol and chemistry expertise to address each of these uncertainties in a more quantitative fashion than is currently possible. With the current LDRD support, we are in the process to implement an aerosol microphysics module into our global chemistry model to more fundamentally and completely describe the processes that determine the distribution of atmospheric aerosols. Using this new modeling capability, in conjunction with the most current version of NCAR climate model, we will examine the influence of these processes on aerosol direct and indirect climate forcing

Parameterization of coarse-grained models: Comparison between radius of gyration of various intrinsically disordered proteins from experiment, and from simulation with the optimal parameters.

<p>Parameterization of coarse-grained models: Comparison between radius of gyration of various intrinsically disordered proteins from experiment, and from simulation with the optimal parameters.</p

Phase diagram for FUS WT, 6E variants and 12E.

<p>Temperatures are scaled by the critical temperature of FUS WT.</p

Phase separation of truncated FUS fragments of different lengths.

<p>a) Phase diagram for each peptide. Dashed lines show the fitting to binodal of Flory-Huggins theory. b) The critical temperature. Dashed lines show the fitting using relation with prefactor as the fitting parameter. c) The critical concentration. Dashed lines show the fitting using relation with prefactor as the fitting parameter. Temperatures are scaled by the critical temperature of [FUS40]₁. The corresponding slab density profiles are provided in <a href="http://www.ploscompbiol.org/article/info:doi/10.1371/journal.pcbi.1005941#pcbi.1005941.s018" target="_blank">S18 Fig</a>.</p